Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Hays

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Regulatory Toxicology and Pharmacology : RTP|November 8, 2017
Derivation of endogenous equivalent values to support risk assessment and risk management decisions for an endogenous carcinogen: Ethylene oxideC R Kirman, S M Hays
Regulatory Toxicology and Pharmacology : RTP|November 19, 2015
Interpreting biomonitoring data for 2,4-dichlorophenoxyacetic acid: Update to Biomonitoring Equivalents and population biomonitoring dataL L Aylward, S M Hays
Social Science & Medicine (1982)|January 1, 1990
Spatial patterns of attendance at general practitioner servicesS M Hays, R A Kearns, W Moran
Regulatory Toxicology and Pharmacology : RTP|April 22, 2008
Introduction to the Biomonitoring Equivalents Pilot Project: development of guidelines for the derivation and communication of Biomonitoring EquivalentsS M Hays, L L Aylward, J S Lakind
Regulatory Toxicology and Pharmacology : RTP|January 12, 2019
Science peer review for the 21st century: Assessing scientific consensus for decision-making while managing conflict of interests, reviewer and process biasC R Kirman, T W Simon, S M Hays
Toxicology|October 28, 1996
Using PBPK modeling and comprehensive realism methodology for the quantitative cancer risk assessment of butadieneR L Sielken, R H Reitz, S M Hays
Toxicology and Applied Pharmacology|April 9, 2017
Improved physiologically based pharmacokinetic model for oral exposures to chromium in mice, rats, and humans to address temporal variation and sensitive populationsC R Kirman, M Suh, D M Proctor, et al.
Regulatory Toxicology and Pharmacology : RTP|February 7, 2016
Derivation of a No-significant-risk-level (NSRL) for dermal exposures to diethanolamineC R Kirman, B Hughes, R A Becker, et al.
Regulatory Toxicology and Pharmacology : RTP|June 11, 2018
Biomonitoring Equivalents for cyanideC R Kirman, A M Belknap, A F Webster, et al.
Journal of Toxicology and Environmental Health. Part A|February 18, 2003
Rapid communication: partitioning of persistent lipophilic compounds, including dioxins, between human milk lipid and blood lipid: an initial assessmentL L Aylward, S M Hays, J S LaKind, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Regulatory Toxicology and Pharmacology : RTP|November 8, 2017
Derivation of endogenous equivalent values to support risk assessment and risk management decisions for an endogenous carcinogen: Ethylene oxideC R Kirman, S M Hays
Regulatory Toxicology and Pharmacology : RTP|November 19, 2015
Interpreting biomonitoring data for 2,4-dichlorophenoxyacetic acid: Update to Biomonitoring Equivalents and population biomonitoring dataL L Aylward, S M Hays
Social Science & Medicine (1982)|January 1, 1990
Spatial patterns of attendance at general practitioner servicesS M Hays, R A Kearns, W Moran
Regulatory Toxicology and Pharmacology : RTP|April 22, 2008
Introduction to the Biomonitoring Equivalents Pilot Project: development of guidelines for the derivation and communication of Biomonitoring EquivalentsS M Hays, L L Aylward, J S Lakind
Regulatory Toxicology and Pharmacology : RTP|January 12, 2019
Science peer review for the 21st century: Assessing scientific consensus for decision-making while managing conflict of interests, reviewer and process biasC R Kirman, T W Simon, S M Hays
Toxicology|October 28, 1996
Using PBPK modeling and comprehensive realism methodology for the quantitative cancer risk assessment of butadieneR L Sielken, R H Reitz, S M Hays
Toxicology and Applied Pharmacology|April 9, 2017
Improved physiologically based pharmacokinetic model for oral exposures to chromium in mice, rats, and humans to address temporal variation and sensitive populationsC R Kirman, M Suh, D M Proctor, et al.
Regulatory Toxicology and Pharmacology : RTP|February 7, 2016
Derivation of a No-significant-risk-level (NSRL) for dermal exposures to diethanolamineC R Kirman, B Hughes, R A Becker, et al.
Regulatory Toxicology and Pharmacology : RTP|June 11, 2018
Biomonitoring Equivalents for cyanideC R Kirman, A M Belknap, A F Webster, et al.
Journal of Toxicology and Environmental Health. Part A|February 18, 2003
Rapid communication: partitioning of persistent lipophilic compounds, including dioxins, between human milk lipid and blood lipid: an initial assessmentL L Aylward, S M Hays, J S LaKind, et al.
Pageof 4